NIB biotec at the AUA Innovation Nexus Showcase 2026

Next May 14th represents a fundamental step for the international growth path of NIB biotec: we will be among the startups selected to take the stage atAUA Innovation Nexus Showcase 2026, the event dedicated to innovation in urology that will open the annual congress of the American Urological Association (AUA), at the prestigious Walter E. Washington Convention Center in Washington.

A globally significant event, which annually brings together the key players in the urology ecosystem: clinicians, researchers, companies, investors, and innovators from around the world.

From Boot Camp to the International Forum

For NIB biotec, participation in the Innovation Nexus Showcase represents the natural continuation of a path that began with theInnovation Nexus Boot Camp 2025.

During that experience, we had the opportunity to engage with international experts, delving into key aspects such as clinical validation, regulatory processes, and US market access strategies. This crucial moment helped strengthen our vision and consolidate our entrepreneurial project.

Today, being invited to present on the Forum stage confirms the value of the work done and the potential of our technology in the panorama of urological innovation.

A stage for innovation

During the event, we will have the opportunity to present our solution to a highly qualified audience of investors, medical industry experts, and international stakeholders, along with other selected global startups.

It will be a unique opportunity to share the value of our innovation: a rapid diagnostic test based on urinary biomarkers, designed to improve early diagnosis and management of prostate cancer.

Bringing our technology to such a prominent stage represents not only a significant milestone for us, but also a responsibility towards clinical innovation and towards patients.

A moment of learning and comparison

The AUA Innovation Nexus Showcase is not just about visibility, but also a significant growth opportunity. The day will be enriched with sessions dedicated to key topics for the development and commercialization of medical technologies, including:

• regulatory aspects and approval processes
• clinical validation of technologies
• reimbursement strategies
• evaluation of clinical and economic impact
• access to capital and investments

A highly stimulating environment that fosters discussion and the exchange of experiences among innovators, experts, and investors, helping to strengthen our international development strategy.

Looking forward

Being among the protagonists of the Innovation Nexus Forum 2026 represents a further step for NIB biotec towards our goal: to bring innovative, accessible and high clinical impact diagnostic solutions to the market.

This milestone confirms our commitment to contributing to the advancement of personalized medicine in urology and improving patients' quality of life through simpler, faster, and more reliable diagnostic tools.

We will continue to work with determination, knowing that every new opportunity represents a step forward towards realizing our vision.